Wezlana
![Wezlana Challenges Stelara in Medicare Negotiations: Amgen's Biosimilar on the Horizon](https://pharmtales.com/wp-content/uploads/2023/11/Amgens-Wezlana-Emerges-as-Competitor-to-JJs-Stelara-Shaping-Medicare-Negotiations.jpg)
Amgen’s Wezlana Emerges as Competitor to J&J’s Stelara, Shaping Medicare Negotiations
Anika Sharma
Johnson & Johnson may find a silver lining in the recent FDA approval of Amgen’s biosimilar for Stelara. This approval ...
Johnson & Johnson may find a silver lining in the recent FDA approval of Amgen’s biosimilar for Stelara. This approval ...